These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 25069082

  • 1. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C.
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [Abstract] [Full Text] [Related]

  • 2. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M, Adli M, Bschor T, Pilhatsch M, Pfennig A, Sasse J, Schmid R, Lewitzka U.
    Neuropsychobiology; 2010 Oct; 62(1):36-42. PubMed ID: 20453533
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU.
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [Abstract] [Full Text] [Related]

  • 4. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 5. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.
    Crossley NA, Bauer M.
    J Clin Psychiatry; 2007 Jun; 68(6):935-40. PubMed ID: 17592920
    [Abstract] [Full Text] [Related]

  • 6. Role of lithium augmentation in the management of major depressive disorder.
    Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M.
    CNS Drugs; 2014 Apr; 28(4):331-42. PubMed ID: 24590663
    [Abstract] [Full Text] [Related]

  • 7. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.
    Connolly KR, Thase ME.
    Drugs; 2011 Jan 01; 71(1):43-64. PubMed ID: 21175239
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.
    Nelson JC, Delucchi K, Schneider LS.
    Am J Geriatr Psychiatry; 2008 Jul 01; 16(7):558-67. PubMed ID: 18591576
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
    Vázquez GH, Bahji A, Undurraga J, Tondo L, Baldessarini RJ.
    J Psychopharmacol; 2021 Aug 01; 35(8):890-900. PubMed ID: 34238049
    [Abstract] [Full Text] [Related]

  • 10. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
    Beasley CM, Koke SC, Nilsson ME, Gonzales JS.
    Clin Ther; 2000 Nov 01; 22(11):1319-30. PubMed ID: 11117656
    [Abstract] [Full Text] [Related]

  • 11. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B, Alevizos E, Leonardou A, Zervas I.
    Psychiatriki; 2012 Nov 01; 23(2):143-8. PubMed ID: 22796912
    [Abstract] [Full Text] [Related]

  • 12. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M, Adli M, Baethge C, Berghöfer A, Sasse J, Heinz A, Bschor T.
    Can J Psychiatry; 2003 Aug 01; 48(7):440-8. PubMed ID: 12971013
    [Abstract] [Full Text] [Related]

  • 13. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
    Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S.
    Eur Neuropsychopharmacol; 2018 Dec 01; 28(12):1305-1313. PubMed ID: 30446357
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.
    Nelson JC, Papakostas GI.
    Am J Psychiatry; 2009 Sep 01; 166(9):980-91. PubMed ID: 19687129
    [Abstract] [Full Text] [Related]

  • 15. Lithium treatment for unipolar major depressive disorder: Systematic review.
    Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ.
    J Psychopharmacol; 2019 Feb 01; 33(2):167-176. PubMed ID: 30698058
    [Abstract] [Full Text] [Related]

  • 16. Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
    Zheng W, Zhang YF, Zhong HQ, Mai SM, Yang XH, Xiang YT.
    East Asian Arch Psychiatry; 2016 Sep 01; 26(3):87-97. PubMed ID: 27703096
    [Abstract] [Full Text] [Related]

  • 17. Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
    Kok RM, Vink D, Heeren TJ, Nolen WA.
    J Clin Psychiatry; 2007 Aug 01; 68(8):1177-85. PubMed ID: 17854241
    [Abstract] [Full Text] [Related]

  • 18. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.
    Bauer M, Dopfmer S.
    J Clin Psychopharmacol; 1999 Oct 01; 19(5):427-34. PubMed ID: 10505584
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A, de Filippis R, Proietti L.
    World J Psychiatry; 2015 Sep 22; 5(3):330-41. PubMed ID: 26425446
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A, Vöhringer PA, Ghaemi SN, Lam RW, Yatham LN.
    Lancet Psychiatry; 2016 Dec 22; 3(12):1138-1146. PubMed ID: 28100425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.